Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05429255 · ClinicalTrials.gov registry record · NA

Aerobic Exercise in Patients With Stroke

A NA study of Stroke, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05429255 is a NA study of Stroke that has completed, run by Columbia University. The registered enrollment target is 24 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05429255, a NA study of Stroke, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare aerobic training to exergame training in people with chronic mild/moderate stroke. The objectives of this study are two-fold: 1) To evaluate the effects of a home-based aerobic exercise cycle ergometer program on cardiorespiratory fitness, mobility, cognitive, and exercise self-efficacy outcomes in subacute and chronic stroke patients; and 2) to evaluate the effects of an exergaming program on the same outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Exergame Training

Study Locations (1)

New York

  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-06-23
Est. Completion 2024-05-17
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05429255

The ClinicalTrials.gov registry entry for NCT05429255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Aerobic Exercise is the first listed.

NCT05429255 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05429255 about?

NCT05429255 is a clinical study titled "Aerobic Exercise in Patients With Stroke". The purpose of this study is to compare aerobic training to exergame training in people with chronic mild/moderate stroke. The objectives of this study are two-fold: 1) To evaluate the effects of a home-based aerobic exercise cycle ergometer program on cardiorespiratory fitness, mobility, cognitive,...

What is the current status of trial NCT05429255?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-06-23. Estimated completion is 2024-05-17.

What conditions does trial NCT05429255 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT05429255?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Exergame Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05429255?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05429255 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.